Vaccines
News
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...
News from the FDA/CDC
New challenge for docs: End of COVID federal public health emergency
The Biden administration intends to end by May 11 certain COVID-19 emergency measures used to aid in the response to the pandemic.
Commentary
The five biggest changes in the 2023 adult vaccine schedules
COVID vaccines are now front and center among 2023’s five most important changes.
News
AAP approves 2023 child and adolescent immunization schedule
The updated recommendations do not include major changes from those released in 2022 by the Advisory Committee on Immunization Practices, except...
News
Maternal COVID-19 vaccine curbs infant infection
Maternal mRNA COVID-19 vaccination during pregnancy was less effective in protecting infants against omicron.
News
More data back Guillain-Barré risk with Janssen COVID shot
Observed GBS cases after the Janssen shot were 2 to 3 times greater than expected, based on background rates within 21 and 42 days of vaccination...
News
COVID emergency orders ending: What’s next?
There will be cost-sharing changes for COVID-19 vaccines, testing, and certain treatments.
News
Washington medical board charges doctor with spreading COVID misinformation
Doctors and professional organizations are trying to protect patients from any harm that results from mistruths spread by colleagues.
News
FDA wants annual COVID boosters, just like annual flu shots
The booster’s formulation would be selected in June targeting the most threatening COVID-19 strains.
News
Highly anticipated HIV vaccine fails in large trial
The vaccine had been in development since 2019 and was given to 3,900 study participants through October 2022.